![Frank Verwiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Verwiel
Presidente presso
INTELLIA THERAPEUTICS, INC.
Patrimonio netto: 742 613 $ in data 30/06/2026
Profilo
Frank A. G. M. Verwiel è un uomo d'affari olandese che è stato alla guida di 6 diverse aziende. È presidente di ObsEva SA, presidente di Intellia Therapeutics, Inc. e presidente di Aptalis Pharma US, Inc. È anche nel consiglio di amministrazione di Bavarian Nordic An e Bavarian Nordic GmbH. Nella sua carriera passata Frank A. G. M. Verwiel ha occupato la posizione di VP-Hypertension & Worldwide Human Health Marketing presso Merck & Co., Inc., Presidente, Amministratore Delegato e Direttore di Aptalis Pharma, Inc., Presidente e Amministratore Delegato di Aptalis Pharma SAS, Presidente, Amministratore Delegato e Direttore di Aptalis Holdings, Inc. e Direttore e Direttore del Consiglio Direttivo della Sezione Sanità presso Biotechnology Innovation Organization. Frank A. G. M. Verwiel ha ricevuto un MBA dall'INSEAD e un dottorato dall'Università Erasmus di Rotterdam.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/06/2026 | 35.148 ( 0,03% ) | 594 704 $ | 30/06/2026 | |
BAVARIAN NORDIC A/S 0,01% | 31/12/2025 | 5.293 ( 0,01% ) | 147 909 $ | 30/06/2026 |
Posizioni attive di Frank Verwiel
| Società | Posizione | Inizio |
|---|---|---|
| BAVARIAN NORDIC A/S | Direttore/Membro del Consiglio | 20/04/2016 |
| INTELLIA THERAPEUTICS, INC. | Presidente | 01/02/2020 |
Aptalis Pharma US, Inc.
 Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Presidente | - |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Direttore/Membro del Consiglio | 01/01/2016 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Direttore/Membro del Consiglio | 01/08/2019 |
Precedenti posizioni note di Frank Verwiel
| Società | Posizione | Fine |
|---|---|---|
| OBSEVA SA | Presidente | 18/05/2022 |
| ACHILLION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 28/01/2020 |
| AVEXIS INC | Direttore/Membro del Consiglio | 01/06/2018 |
| INTERMUNE INC | Direttore/Membro del Consiglio | 01/09/2014 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Frank Verwiel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Health Technology |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TA SASU
 TA SASU Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on gastrointestinal diseases and cystic fibrosis | Health Technology |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Health Technology |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operating as a holding company that develops, manufactures, licenses, markets and distributes therapies | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
